top of page

Current Studies

Welcome to Sana Research! We are dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical trials. Specializing in neurologic diseases, our mission is to enroll and support patients in cutting-edge research studies that explore new treatments and therapies. At Sana Research, we are committed to excellence in clinical trial management, patient care, and scientific rigor, striving to bring hope and healing to those affected by neurological conditions.

Dementia with Lewy Bodies (DLB)

Dementia with Lewy Bodies affects more than 1 million people in the US. There are no FDA approved targeted therapies for DLB yet. The REWIND-LB study is investigating a new oral treatment.

Agitation due to Alzheimer's Disease

The majority of patients with Alzheimer's Disease will eventually developed agitation symptoms which increases the complexity and workload of caregivers. Clinically proven treatments are limited.


Please email us your information if you or your family member are interested to learn more about active research studies. A member of our staff will contact you.


Privacy is our top priority: Sana Research will never sell or provide access to your information to any third parties or companies without your permission.


Thanks for submitting!

bottom of page